Last reviewed · How we verify
NCT04961112
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
NA trial testing Cranial Electrotherapy Stimulation in Anxiety in 124 participants. Completed in 7 April 2025.
7 April 2025
Quick facts
| Lead sponsor | Tufts University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 124 |
| Start date | 6 September 2021 |
| Primary completion | 7 April 2025 |
| Estimated completion | 7 April 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cranial Electrotherapy Stimulation
- Sham Cranial Electrotherapy Stimulation
Conditions studied
- Anxiety — all drugs for Anxiety →
- Cognitive Deficit — all drugs for Cognitive Deficit →
Sponsor
Tufts University
Who can join
Adults 18 to 28, any sex, with Anxiety or Cognitive Deficit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04961112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cranial Electrotherapy Stimulation
Trials testing the same drug.
- NCT04587531 — Neural Mechanisms With CES in Depression · NA · terminated
- NCT03222752 — Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder · NA · terminated
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Tufts University trials
Trials by the same sponsor.
- NCT07249242 — Healing Outcomes of Peri-implant Soft Tissues With Different Healing Abutments · NA · recruiting
- NCT07099131 — Effective Interventions to Overcome Severe Gag Reflex · EARLY_PHASE1 · not yet recruiting
- NCT06428630 — Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus · EARLY_PHASE1 · withdrawn
- NCT06526221 — Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India · NA · not yet recruiting
- NCT06352645 — Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04961112 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tufts University
- Last refreshed: 10 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing